Why Is Taiwan's Deep-Tech Cluster Taking Root in Boston?

Taiwanese deep-tech entrepreneurs are establishing a cluster in Boston, leveraging MIT, Harvard, and Kendall Square's biotech ecosystem to advance AI-driven drug discovery, industrial AI, and advanced materials. Companies like PharmaEssentia and Vizuro are using Boston's talent and infrastructure to compress R&D timelines and target underdigitised markets with AI solutions.

This Wire brief sits within Fusion42's coverage of AI Frontier Models, Drug Discovery and Advanced Materials. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.